Based in Finland, Oy Reagena Ltd (Reagena) is an emerging diagnostics company in the Nordic region, focused on developing novel POC immunoassay tests in the areas of infectious disease testing and immunity. Aimed at developing biomarker based novel rapid tests, Reagena´s unique ReaMobile™ Diagnostic Test System commands respect in the POC testing market as it aids in faster diagnosis and treatment to patients.

Frost & Sullivan said: “As the product is determined to address the needs of patients quickly and effectively, wireless ReaMobile™ Diagnostic Test System finds a unique place in the market as the need for faster diagnosis in the immunoassay segment is yet to be fulfilled by any product in the market. With an ability to provide both quantitative and qualitative results, this Test System utilizing a mobile hand held reader is a valuable product addition in the market, thereby making Oy Reagena Ltd a deserving recipient of the 2008 Frost & Sullivan Product Differentiation Innovation Award in the European Point-of-Care Immunoassay market”.

Markku Parviainen, CEO of Reagena,commented: “Reagena is pleased to announce receiving the Award. ReaMobile™ Diagnostic Test System is developed and produced with a solid scientific basis of our product development. Our proprietary test technology together with the wireless ReaScan™ hand held rapid test reader, ReaLink™ Bluetooth device and ReaMobile™ application software are also available to partnerships.

'We will be exhibiting our products at Medica 2008 in Düsseldorf November 19-22 and we are seeking new partners.'